VENTIZOLVE 1.26 mg, solution as a nasal spray in a single-dose container 2 bottles of 0.1 ml
Active ingredients: Naloxone hydrochloride dihydrate, Naloxone
Commercialized according to BDPM
Solution for spraying2 bottles of 0.1 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VENTIZOLVE 1,26 mg, solution pour pulvérisation nasale en récipient unidose
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 2 flacons pulvérisateurs unidoses en verre de 0,1 mL
- Marketing authorisation holder
- NAVAMEDIC (NORVEGE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Oct 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66569422CIP73016168CIP133400930161685Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NALOXONEsolution | 1,26 mg · un récipient unidose | FT |
| CHLORHYDRATE DE NALOXONE DIHYDRATÉsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.